# Supriya Lifescience Ltd (SUPRIYA)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹733.9
Day Change: +1.19%
52W High: ₹832.4
52W Low: ₹545.5
Market Cap: ₹5,505 Cr

## Valuation
P/E: 29.65
P/B: 5.09
EPS: ₹23.07
Book Value: ₹134.51
Dividend Yield: 0%

## Returns
1Y Return: -10.28%

## Profitability
ROE: 0%
ROCE: 32.43%
Debt/Equity: 0
Revenue Growth: 11.2%
Profit Growth: 6%
EBITDA Margin: 35.52%
Operating Margin: 31.61%

## About
Supriya Lifescience Ltd is a Biotechnology company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: Supriya Lifescience Ltd makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- Announcement: Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Update On Inspection By United States Food & Drug Administration (USFDA)
- BSE Filing: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-21T20:00:05.656Z
Price History Updated: 2026-05-18T22:58:36.460Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:36.460Z
Quant Updated: 2026-05-18T22:58:36.460Z
Sentiment Updated: 2026-05-18T22:58:36.460Z
Financials Status: current
Financials Updated: 2026-05-18T12:31:58.833Z
Financials Last Attempt: 2026-05-18T12:31:58.833Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹679.56 Cr
Operating Profit: ₹235.89 Cr (OPM 34.71%)
Net Profit: ₹187.96 Cr
Tax: ₹60.52 Cr

## Annual P&L History
FY25: Rev ₹679.56Cr | PAT ₹187.96Cr | OPM 34.71%
FY24: Rev ₹557.41Cr | PAT ₹119.11Cr | OPM 28.3%
FY23: Rev ₹451.02Cr | PAT ₹89.86Cr | OPM 25.57%

## Balance Sheet (FY25)
Total Assets: ₹1112.31 Cr
Total Liabilities: ₹115.55 Cr
Borrowings: ₹5.38 Cr
Cash: ₹76 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Satish Waman Wagh, Founder, Executive Chairman & Whole Time Director
- Saloni Satish Wagh, Managing Director
- Shivani Satish Wagh, Joint Managing Director
- Krishna  Raghunathan, Chief Financial Officer
- Sushanta Kumar Gouranga Mishra, Chief Scientific Officer

---
Source: rupiya.io/stocks/supriya
Disclaimer: For research and education only. Not investment advice.